BACKGROUND: Polyamines are important in cell growth and wound repair, but have also been implicated in inflammation-induced carcinogenesis. Polyamine metabolism includes back-conversion of spermine to spermidine by the enzyme spermine oxidase (SMO), which produces hydrogen peroxide that causes oxidative stress. In ulcerative colitis (UC), levels of spermine are decreased compared to spermidine. Therefore, we sought to determine if SMO is involved in UC. METHODS: Colon biopsies and clinical information from subjects undergoing colonoscopy for evaluation of UC or colorectal cancer screening were utilized from 16 normal controls and 53 UC cases. Histopathologic disease severity was graded and the Mayo Disease Activity Index (DAI) and endoscopy subscore assessed. SMO mRNA expression was measured in frozen biopsies by TaqMan-based real-time polymerase chain reaction (PCR). Formalin-fixed tissues were used for SMO immunohistochemistry. RESULTS: There was a 3.1-fold upregulation of SMO mRNA levels in UC patients compared to controls (P = 0.044), and a 3.7-fold increase in involved left colon versus paired uninvolved right colon (P < 0.001). With worsening histologic injury in UC there was a progressive increase in SMO staining of mononuclear inflammatory cells. There was a similar increase in SMO staining with worsening endoscopic disease severity and strong correlation with the DAI (r = 0.653, P < 0.001). Inflammatory cell SMO staining was increased in involved left colon versus uninvolved right colon. CONCLUSIONS: SMO expression is upregulated in UC tissues, deriving from increased levels in mononuclear inflammatory cells. Dysregulated polyamine homeostasis may contribute to chronic UC by altering immune responses and increasing oxidative stress.
BACKGROUND:Polyamines are important in cell growth and wound repair, but have also been implicated in inflammation-induced carcinogenesis. Polyamine metabolism includes back-conversion of spermine to spermidine by the enzyme spermine oxidase (SMO), which produces hydrogen peroxide that causes oxidative stress. In ulcerative colitis (UC), levels of spermine are decreased compared to spermidine. Therefore, we sought to determine if SMO is involved in UC. METHODS: Colon biopsies and clinical information from subjects undergoing colonoscopy for evaluation of UC or colorectal cancer screening were utilized from 16 normal controls and 53 UC cases. Histopathologic disease severity was graded and the Mayo Disease Activity Index (DAI) and endoscopy subscore assessed. SMO mRNA expression was measured in frozen biopsies by TaqMan-based real-time polymerase chain reaction (PCR). Formalin-fixed tissues were used for SMO immunohistochemistry. RESULTS: There was a 3.1-fold upregulation of SMO mRNA levels in UC patients compared to controls (P = 0.044), and a 3.7-fold increase in involved left colon versus paired uninvolved right colon (P < 0.001). With worsening histologic injury in UC there was a progressive increase in SMO staining of mononuclear inflammatory cells. There was a similar increase in SMO staining with worsening endoscopic disease severity and strong correlation with the DAI (r = 0.653, P < 0.001). Inflammatory cell SMO staining was increased in involved left colon versus uninvolved right colon. CONCLUSIONS:SMO expression is upregulated in UC tissues, deriving from increased levels in mononuclear inflammatory cells. Dysregulated polyamine homeostasis may contribute to chronic UC by altering immune responses and increasing oxidative stress.
Authors: Yanlin Wang; Tracy Murray-Stewart; Wendy Devereux; Amy Hacker; Benjamin Frydman; Patrick M Woster; Robert A Casero Journal: Biochem Biophys Res Commun Date: 2003-05-16 Impact factor: 3.575
Authors: Alain P Gobert; Yulan Cheng; Jian-Ying Wang; Jean-Luc Boucher; Ramaswamy K Iyer; Stephen D Cederbaum; Robert A Casero; Jamie C Newton; Keith T Wilson Journal: J Immunol Date: 2002-05-01 Impact factor: 5.422
Authors: Frank L Meyskens; Christine E McLaren; Daniel Pelot; Sharon Fujikawa-Brooks; Philip M Carpenter; Ernest Hawk; Gary Kelloff; Michael J Lawson; Jayashri Kidao; John McCracken; C Gregory Albers; Dennis J Ahnen; D Kim Turgeon; Steven Goldschmid; Peter Lance; Curt H Hagedorn; Daniel L Gillen; Eugene W Gerner Journal: Cancer Prev Res (Phila) Date: 2008-06
Authors: Wendy Devereux; Yanlin Wang; Tracy Murray Stewart; Amy Hacker; Renee Smith; Benjamin Frydman; Aldonia L Valasinas; Venodhar K Reddy; Laurence J Marton; Tracey D Ward; Patrick M Woster; Robert A Casero Journal: Cancer Chemother Pharmacol Date: 2003-06-25 Impact factor: 3.333
Authors: R A Casero; Y Wang; T M Stewart; W Devereux; A Hacker; Y Wang; R Smith; P M Woster Journal: Biochem Soc Trans Date: 2003-04 Impact factor: 5.407
Authors: Rupesh Chaturvedi; Mohammad Asim; Judith Romero-Gallo; Daniel P Barry; Svea Hoge; Thibaut de Sablet; Alberto G Delgado; Lydia E Wroblewski; M Blanca Piazuelo; Fang Yan; Dawn A Israel; Robert A Casero; Pelayo Correa; Alain P Gobert; D Brent Polk; Richard M Peek; Keith T Wilson Journal: Gastroenterology Date: 2011-08-10 Impact factor: 22.682
Authors: Alain P Gobert; Mohammad Asim; M Blanca Piazuelo; Thomas Verriere; Brooks P Scull; Thibaut de Sablet; Ashley Glumac; Nuruddeen D Lewis; Pelayo Correa; Richard M Peek; Rupesh Chaturvedi; Keith T Wilson Journal: J Immunol Date: 2011-10-10 Impact factor: 5.422
Authors: Andrew C Goodwin; Christina E Destefano Shields; Shaoguang Wu; David L Huso; XinQun Wu; Tracy R Murray-Stewart; Amy Hacker-Prietz; Shervin Rabizadeh; Patrick M Woster; Cynthia L Sears; Robert A Casero Journal: Proc Natl Acad Sci U S A Date: 2011-08-29 Impact factor: 11.205